News & Updates

GLP‐1RA, SGLT2i confer benefits for BP, weight in diabetic patients

01 May 2020

Treatment with glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) yields significant blood pressure (BP) reductions, as driven by weight loss, in patients with type 2 diabetes mellitus, according to the results of a meta-analysis.

GLP‐1RA, SGLT2i confer benefits for BP, weight in diabetic patients

01 May 2020

Frontline maintenance immunotherapy ups RFS in ovarian cancer

30 Apr 2020 by

Frontline maintenance treatment with a DNA engineered autologous tumour cell (EATC) immunotherapy yields relapse-free survival (RFS) benefit in patients with advanced epithelial ovarian cancer, particularly in those with wild-type BRCA1/2 status, according to the VITAL* study presented at the 2020 SGO Annual Meeting.

Frontline maintenance immunotherapy ups RFS in ovarian cancer

30 Apr 2020

Increased osteoporosis risk in young, gynae cancer survivors

30 Apr 2020 by

Young gynaecological cancer survivors have an increased risk of bone mineral density (BMD) reductions and osteoporosis, according to a study scheduled for presentation at SGO 20/20.

Increased osteoporosis risk in young, gynae cancer survivors

30 Apr 2020

Dapansutrile may drive gout flares down

30 Apr 2020 by

The novel selective NLRP3* inflammasome inhibitor dapansutrile markedly reduced joint pain in patients with monoarticular gout flares, according to a proof-of-concept study.

Dapansutrile may drive gout flares down

30 Apr 2020

Valproic acid useful for managing agitation, delirium in intensive care

30 Apr 2020

Valproic acid provides a reasonable and tolerable alternative in the management of agitation and delirium in critically ill patients, a study has found.

Valproic acid useful for managing agitation, delirium in intensive care

30 Apr 2020

Single-inhaler triple therapy ups survival in COPD

29 Apr 2020 by

A once-daily triple therapy of fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; ICS/LAMA/LABA*) in a single inhaler significantly reduces the risk of all-cause mortality compared with a dual therapy of UMEC/VI (LAMA/LABA) in chronic obstructive pulmonary disease (COPD) patients with a history of moderate or severe exacerbations, confirm the latest results of the IMPACT** study.

Single-inhaler triple therapy ups survival in COPD

29 Apr 2020

The workplace: An avenue for hypertension management?

29 Apr 2020 by

A workplace-based hypertension management programme conducted in China resulted in improved blood pressure (BP) control and reduced hypertension rates.

The workplace: An avenue for hypertension management?

29 Apr 2020

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

29 Apr 2020

The monoamine oxidase inhibitor phenelzine shows therapeutic potential in patients with biochemical recurrent castrate-sensitive prostate cancer, with manageable treatment-related toxicities, according to the results of a phase II trial.

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

29 Apr 2020

Drug survival longer with etanercept vs other TNFi for rheumatoid arthritis

29 Apr 2020

There are more rheumatoid arthritis (RA) patients receiving etanercept (ETN) who remain on treatment compared with those taking other tumour necrosis factor inhibitors (TNFi) after >12 months of follow-up, reports a study.

Drug survival longer with etanercept vs other TNFi for rheumatoid arthritis

29 Apr 2020

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

29 Apr 2020 by

Inhibitors of the renin-angiotensin system may not exacerbate the coronavirus disease 2019 (COVID-19) in patients with hypertension, according to a recent study.

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

29 Apr 2020

News & Updates

Filter by Specialty:

Specialty:

GLP‐1RA, SGLT2i confer benefits for BP, weight in diabetic patients

GLP‐1RA, SGLT2i confer benefits for BP, weight in diabetic patients

Frontline maintenance immunotherapy ups RFS in ovarian cancer

Frontline maintenance immunotherapy ups RFS in ovarian cancer

Increased osteoporosis risk in young, gynae cancer survivors

Increased osteoporosis risk in young, gynae cancer survivors

Dapansutrile may drive gout flares down

Dapansutrile may drive gout flares down

Valproic acid useful for managing agitation, delirium in intensive care

Valproic acid useful for managing agitation, delirium in intensive care

Single-inhaler triple therapy ups survival in COPD

Single-inhaler triple therapy ups survival in COPD

The workplace: An avenue for hypertension management?

The workplace: An avenue for hypertension management?

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

Phenelzine beneficial against recurrent castrate-sensitive prostate cancer

Drug survival longer with etanercept vs other TNFi for rheumatoid arthritis

Drug survival longer with etanercept vs other TNFi for rheumatoid arthritis

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients